- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Skyepharma Share News (SKP)
Share News for Skyepharma (SKP)
| Share Price: 48.25 | Bid: 48.25 | Ask: 53.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
Skyepharma says Abbott's purchase of Kos Pharma 'positive' for Flutiform
LONDON (AFX) - Skyepharma PLC said the purchase of Kos Pharmaceuticals Inc by Abbott Laboratories Inc is a 'positive' development for its asthma[7 Nov '06]
UK smallcap opening - Skyepharma gains as partner receives FDA acceptance
LONDON (AFX) - Shares in Skyepharma PLC gained 0-1/4 pence to 25-3/4 after the pharmaceutical firm said its partner Critical Therapeutics Inc ha[24 Oct '06]
Skyepharma says Critical Therapeutics' asthma drug Zileuton gets FDA acceptance
LONDON (AFX) - Skyepharma PLC said its partner Critical Therapeutics, Inc has received FDA acceptance for its New Drug Application for the twice[24 Oct '06]
UK smallcap opening - Skyepharma up after positive drug results
LONDON (AFX) - Better levels were seen in Skyepharma, 1-1/4 pence up at 27-1/2, following positive results from a phase III trial of an anti-inf[4 Oct '06]
UK smallcap opening - Skyepharma up after positive drug results
LONDON (AFX) - Better levels were seen in Skyepharma, 1-1/4 pence up at 27-1/2, following positive results from a phase III trial of an anti-inf[4 Oct '06]
Skyepharma announces positive results for reformulated arthritis drug UPDATE
(Adds detail, share price) LONDON (AFX) - Skyepharma PLC announced positive results from a phase III trial of a reformulated anti-inflammato[4 Oct '06]
Skyepharma announces positive results for reformulated arthritis drug
LONDON (AFX) - Skyepharma PLC announced positive results from a phase III trial of an anti-inflammatory drug used to treat the pain and stiffnes[4 Oct '06]
Skyepharma H1 losses widen as revenues fall, costs soar UPDATE
(Adds detail) LONDON (AFX) - British drug delivery group Skyepharma PLC unveiled widening interim losses after revenues dropped and the comp[28 Sep '06]
